Jushi Holdings (JUSHF) Other Non-Current Liabilities (2021 - 2026)

Jushi Holdings' (JUSHF) quarterly Other Non-Current Liabilities came in at $30.8 million in Q1 2026, up 967.98% year-on-year from $2.9 million in Q1 2025, and down 7.27% on a QoQ basis from $33.2 million in Q4 2025.

Jushi Holdings (JUSHF) Other Non-Current Liabilities (2021 - 2026) Analysis & Trends

Jushi Holdings (JUSHF) has 6 years of Other Non-Current Liabilities data on file, last reported at $30.8 million in Q1 2026.

  • On a quarterly basis, Other Non-Current Liabilities rose 967.98% year-over-year to $30.8 million in Q1 2026; TTM through Mar 2026 was $30.8 million, a 967.98% increase from a year earlier, with the FY2025 full-year figure at $33.2 million, down 14.09% from the prior year.
  • Other Non-Current Liabilities for Q1 2026 stood at $30.8 million, down from $33.2 million in the prior quarter.
  • Over the last five years, Other Non-Current Liabilities for JUSHF reached as high as $136.1 million in Q3 2024 and fell as low as $2.9 million in Q1 2025.
  • Historically, Other Non-Current Liabilities has averaged $47.6 million across 5 years, with a median of $31.5 million in 2023.
  • Across the five-year window, Other Non-Current Liabilities surged 1689.06% in 2024 and slumped 97.59% in 2025, its largest moves.
  • Year by year, Other Non-Current Liabilities stood at $14.1 million in 2022, then soared by 640.24% to $104.6 million in 2023, then tumbled by 63.06% to $38.7 million in 2024, then dropped by 14.09% to $33.2 million in 2025, then decreased by 7.27% to $30.8 million in 2026.
  • Per Business Quant data, the three most recent Other Non-Current Liabilities figures were $30.8 million in Q1 2026, $33.2 million in Q4 2025, and $9.4 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Haleon 87.22 Bn 85.35 Bn -
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn
10 Jushi Holdings 81.25 Mn 41.54 Mn 29.88 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 30.79 Mn
Dec 31, 2025 33.21 Mn
Sep 30, 2025 9.40 Mn
Jun 30, 2025 3.07 Mn
Mar 31, 2025 2.88 Mn
Dec 31, 2024 38.65 Mn
Sep 30, 2024 136.09 Mn
Jun 30, 2024 127.14 Mn
Mar 31, 2024 109.20 Mn
Dec 31, 2023 104.63 Mn
Sep 30, 2023 10.57 Mn
Jun 30, 2023 31.45 Mn
Mar 31, 2023 6.10 Mn
Dec 31, 2022 14.13 Mn
Sep 30, 2022 19.80 Mn
Jun 30, 2022 71.10 Mn
Mar 31, 2022 61.28 Mn
Dec 31, 2021 92.44 Mn